Financials
- Market Capitalization 113.77 M
- Employee 8
- Founded 2020
- CEO N/A
- Website www.coyatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00Z4HBCB9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3918 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.93 USD | -6.76% | -15.35% | +6.63% | -61.78% | 116.42 M USD | ||
| 3924 | PMN ProMIS Neurosciences Inc. - Common Shares | 12.80 USD | -10.18% | -7.25% | +23.67% | +2947.62% | 114.79 M USD | ||
| 3932 | NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 4.32 USD | -3.79% | -4.42% | -10.00% | -50.71% | 112.38 M USD | ||
| 3938 | ONCY Oncolytics Biotech Inc. - Common Stock | 0.93 USD | +4.49% | +5.68% | +13.41% | -22.50% | 111.00 M USD |
Frequently asked questions about Coya Therapeutics, Inc. - Common Stock
What is the Coya Therapeutics, Inc. - Common Stock stock price today?
The current price of Coya Therapeutics, Inc. - Common Stock (COYA) is 4.85. Over the past 24 hours, the stock has changed by -7.79%. Follow the COYA chart for real-time price dynamics.
What is the stock ticker of Coya Therapeutics, Inc. - Common Stock?
Coya Therapeutics, Inc. - Common Stock trades under the ticker COYA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Coya Therapeutics, Inc. - Common Stock stock going up?
COYA has changed by -16.09% over the last week, +1.46% over the last month, and -20.88% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Coya Therapeutics, Inc. - Common Stock net income for the last quarter?
Coya Therapeutics, Inc. - Common Stock reported net income of -7.21 M for the last quarter. The previous quarter showed -5.71 M, which means net income changed by -26.25%.
How many employees does Coya Therapeutics, Inc. - Common Stock have?
As of the latest available data, Coya Therapeutics, Inc. - Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.
What is Coya Therapeutics, Inc. - Common Stock EBITDA?
Coya Therapeutics, Inc. - Common Stock EBITDA is -7.64 M, and its EBITDA margin is -3 041.01%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Coya Therapeutics, Inc. - Common Stock stock?
You can buy Coya Therapeutics, Inc. - Common Stock (COYA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Coya Therapeutics, Inc. - Common Stock stock?
Investing in Coya Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COYA chart and related analysis on metatrader.com as part of your research.